NeoGenomics Profit Margin 2006-2021 | NEO
Current and historical gross margin, operating margin and net profit margin for NeoGenomics (NEO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. NeoGenomics net profit margin as of June 30, 2021 is 14.68%.
|NeoGenomics Annual Profit Margins
|NeoGenomics Quarterly Profit Margins
||Medical - Biomedical and Genetics
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.